Two major differences need to be heeded: 1) age, that's good, kids should be the main focus; 2) no specific allergy or parental allergy inclusion criteria as Hollander's. Will this general population open a bigger market, or decrease the efficacy statsig?
Too big egos of the new management. That's my feeling after reading the 8-K. They realized that they made a big mistake, but they don't want to admit it. That's why they don't even want to make a press release about TRUST-1 result and point out some positives to the public. I am still worried they will use the limited fund to buy some in-research products and devest TSO.
Rosenwald, you were wrong firing Dr. Weisman, please don't try to cover that mistake with more mistakes at cost of your investors.